Literature DB >> 8624096

Apolipoprotein E alleles and brain vascular pathology in Alzheimer's disease.

R N Kalaria1, D L Cohen, D R Premkumar.   

Abstract

The presence of apolipoprotein E (ApoE)-E4 allele has been implicated as a risk factor for Alzheimer's disease (AD). We examined the occurrence of ApoE 4 alleles in AD associated with cerebral amyloid angiopathy and other vascular lesions. We found significantly high frequency of the ApoE 4 allele in AD with moderate to severe CAA. The frequency of the allele was also high in AD cases with other vascular lesions such as multiple infarcts and lacunes. As previously reported, we confirm a greater frequency of the ApoE 4 allele in the diffuse Lewy body variant of AD. Our results suggest ApoE 4 allele to be a significant factor in the development of CAA in AD. While this may be related to increased brain amyloid load as a consequence of ApoE genotype, the possibility exists that ApoE may be a specific factor in vascular abnormalities associated with AD.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8624096     DOI: 10.1111/j.1749-6632.1996.tb34430.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  5 in total

1.  APOE genotypes as a risk factor for age-dependent accumulation of cerebrovascular disease in older adults.

Authors:  Melissa Lamar; Lei Yu; Leah H Rubin; Bryan D James; Lisa L Barnes; Jose Marcelo Farfel; Chris Gaiteri; Aron S Buchman; David A Bennett; Julie A Schneider
Journal:  Alzheimers Dement       Date:  2018-10-12       Impact factor: 21.566

2.  Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.

Authors:  D R Premkumar; D L Cohen; P Hedera; R P Friedland; R N Kalaria
Journal:  Am J Pathol       Date:  1996-06       Impact factor: 4.307

Review 3.  Vascular-brain Injury Progression after Stroke (VIPS) study: concept for understanding racial and geographic determinants of cognitive decline after stroke.

Authors:  Fred Stephen Sarfo; Rufus Akinyemi; George Howard; Virginia J Howard; Kolawole Wahab; Mary Cushman; Deborah A Levine; Adesola Ogunniyi; Fred Unverzagt; Mayowa Owolabi; Bruce Ovbiagele
Journal:  J Neurol Sci       Date:  2020-02-19       Impact factor: 4.553

4.  The systemic iron-regulatory proteins hepcidin and ferroportin are reduced in the brain in Alzheimer's disease.

Authors:  Animesh Alexander Raha; Radhika Anand Vaishnav; Robert Paul Friedland; Adrian Bomford; Ruma Raha-Chowdhury
Journal:  Acta Neuropathol Commun       Date:  2013-09-03       Impact factor: 7.801

5.  β-amyloid wall deposit of temporal artery in subjects with spontaneous intracerebral haemorrhage.

Authors:  Antonino Tuttolomondo; Rosario Maugeri; Elisabetta Orlando; Giulio Giannone; Francesco Ciccia; Aroldo Rizzo; Domenico Di Raimondo; Francesca Graziano; Rosaria Pecoraro; Carlo Maida; Irene Simonetta; Anna Cirrincione; Francesca Portelli; Francesca Corpora; Domenico Gerardo Iacopino; Antonio Pinto
Journal:  Oncotarget       Date:  2018-10-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.